- ISIN
- US88331L1089
- CUSIP
- 88331L108
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- IPO Date
- Nov 24, 2020
Highlights
- Market Cap
- $88.29M
- Enterprise Value
- $255.29M
- EPS (TTM)
- -$0.05
- Total Revenue (TTM)
- $296.14M
- Gross Profit (TTM)
- $192.15M
- EBITDA (TTM)
- $36.06M
- Year Range
- $0.55 - $2.69
- Target Price
- $1.30
- ROA (TTM)
- -1.27%
- ROE (TTM)
- -10.90%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SKIN Performance Chart
The Beauty Health Company (SKIN) is down 51.7% since the beginning of the year. At $1 per share, SKIN is trading 75.0% below its 52-week high of $3. Investors who bought $1,000 worth of SKIN shares 5 years ago would now be looking at an investment worth $38.
Loading charts...
Returns By Period
The Beauty Health Company (SKIN) has returned -51.66% so far this year and -58.27% over the past 12 months.
The Beauty Health Company
- 1D
- 1.37%
- 1M
- -2.30%
- YTD
- -51.66%
- 6M
- -55.50%
- 1Y
- -58.27%
- 3Y*
- -55.78%
- 5Y*
- -47.96%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
SKIN Monthly Returns History
Based on dividend-adjusted daily data since Nov 24, 2020, SKIN's average daily return is -0.03%, while the average monthly return is -2.12%.
Historically, 41% of months were positive and 59% were negative. The best month was May 2025 with a return of +64.4%, while the worst month was Jan 2022 at -41.2%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.
On a daily basis, SKIN closed higher 46% of trading days. The best single day was May 9, 2025 with a return of +50.8%, while the worst single day was Nov 14, 2023 at -64.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.91% | -30.67% | -14.42% | -4.30% | -9.15% | -13.17% | -51.66% | ||||||
| 2025 | 5.03% | -11.98% | -8.84% | -26.01% | 64.40% | 17.18% | -19.37% | 35.06% | -4.33% | -28.14% | 3.50% | -6.08% | -12.58% |
| 2024 | -5.79% | 13.65% | 33.33% | -27.25% | -31.58% | -13.12% | -3.65% | -3.24% | -19.55% | 12.15% | -8.36% | 7.43% | -48.87% |
| 2023 | 25.27% | 10.61% | 0.16% | -9.26% | -29.84% | 4.10% | -0.96% | -25.69% | -2.27% | -32.72% | -36.79% | 21.48% | -65.82% |
| 2022 | -41.23% | 36.48% | -12.90% | -22.39% | 8.93% | -9.88% | 3.58% | -12.91% | 1.64% | -3.05% | -5.95% | -15.35% | -62.33% |
| 2021 | -7.43% | 5.44% | -2.17% | 7.13% | 23.08% | 17.98% | 4.52% | 46.41% | 1.01% | 5.78% | -5.50% | -6.93% | 113.62% |
Benchmark Metrics
The Beauty Health Company has an annualized alpha of -28.10%, beta of 1.78, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since November 24, 2020.
- This stock participated in 216.32% of S&P 500 Index downside but only 10.27% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -28.10%
- Beta
- 1.78
- R²
- 0.11
- Upside Capture
- 10.27%
- Downside Capture
- 216.32%
Return for Risk
Risk / Return Rank
SKIN ranks 16 for risk / return — in the bottom 16% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for The Beauty Health Company (SKIN) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SKIN | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.66 | ||
| Sortino ratioReturn per unit of downside risk | -3.44 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.37 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 2.78 | -3.53 |
| Martin ratioReturn relative to average drawdown | -1.19 | 12.44 | -13.62 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the The Beauty Health Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the The Beauty Health Company was 98.03%, occurring on May 8, 2026. The portfolio has not yet recovered.
The current The Beauty Health Company drawdown is 97.72%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -98.03%May 2026 | 4y 6mo | — | 4y 7moNov 2021 - now |
2021 correction2021 | -17.42%Apr 2021 | 3mo 22d | 13d | 4mo 5dDec 2020 - May 2021 |
2021 correction2021 | -15.86%Jul 2021 | 14d | 15d | 29dJul 2021 - Aug 2021 |
2021 correction2021 | -13.75%Sep 2021 | 2d | 14d | 16dSep 2021 - Sep 2021 |
2021 correction2021 | -13.73%Oct 2021 | 17d | 22d | 1mo 9dSep 2021 - Nov 2021 |
Drawdown Indicators
| SKIN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.03% | -56.78% | -41.25% |
Max Drawdown (1Y)Largest decline over 1 year | -77.95% | -9.10% | -68.85% |
Max Drawdown (3Y)Largest decline over 3 years | -93.39% | -18.90% | -74.49% |
Max Drawdown (5Y)Largest decline over 5 years | -98.03% | -25.43% | -72.60% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -97.72% | -1.80% | -95.92% |
Average DrawdownAverage peak-to-trough decline | -65.87% | -10.71% | -55.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 49.19% | 2.03% | +47.16% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of The Beauty Health Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how The Beauty Health Company is priced in the market compared to other companies in the Household & Personal Products industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SKIN relative to other companies in the Household & Personal Products industry. Currently, SKIN has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SKIN in comparison with other companies in the Household & Personal Products industry. Currently, SKIN has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SKIN
Add The Beauty Health Company to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SKIN